As the leader of ZS’s strategy and transformation practice in the Asia-Pacific region, Kelly helps clients at leading pharmaceutical and medical technology companies address an array of business and organizational challenges. She collaborates closely with clients to deliver unparalleled expertise to the successful development and implementation of innovative solutions and initiatives.
Kelly supports organizations with transformative initiatives, from omnichannel customer engagement to patient centricity. She ensures the delivery of personalized experiences that meet patient needs and contribute to improved outcomes.
Kelly is a go-to-market expert and a reliable commercialization and transformation advisor. At the forefront of commercial model innovation and digital transformation, Kelly is recognized for her keen insights and strategic acumen. Her expertise spans a broad range of therapeutic areas and consumer health categories, and she is well-versed in navigating the complexities of the healthcare regulatory environment in China and the Asia-Pacific region.
Kelly started her career as a member of the DuPont Global Marketing Leadership Development Program. She also gained experience with a global top leadership advisory firm. At Abbott Laboratories, Kelly led innovative technology launches as the commercialization director of greater China.
Kelly holds an MBA from Duke University and a B.A. in international trade from East China University of Science and Technology.